Drug intelligence / Profile preview

AKC-1001

Development stage: Preclinical
Lead developer: Akrocell Biosciences
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intramuscular

Overview

AKC-1001 is an advanced cell therapy product consisting of umbilical cord-derived mesenchymal stem cells (UC-MSCs) developed by Akrocell Biosciences. The therapy utilizes the company's proprietary LArGO platform, which is designed for the development of advanced biopharmaceuticals. AKC-1001 is currently in preclinical development for the treatment of myocardial infarction (heart attack) and critical limb ischemia (severe lower limb ischemia). Mesenchymal stem cells are characterized by their ability to migrate to sites of injury and exert therapeutic effects through the secretion of paracrine factors that promote angiogenesis, reduce inflammation, and support tissue regeneration. In the context of myocardial infarction and critical limb ischemia, AKC-1001 aims to restore blood flow and repair damaged vascular and cardiac tissues.

Other names: LArGOAKC-1001 (UC-MSC)

Beyond the preview

Go deeper on AKC-1001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AKC-1001.

Explore the full profile